drugset / Trial / NCT00224432

Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis

NCT00224432 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

To study the effect of supplementation of a hydrolyzed formula with probiotic bacteria on clinical and immunological parameters in infants with AD with and without CMA and to compare effectiveness of different strains of probiotics.

Timeline

Start
2001-03
Primary completion
—
Completion
2002-09

Outcome

Missed primary endpoint

paper No statistically significant effects of probiotic supplementation on SCORAD, sensitization, inflammatory parameters or cytokine production between groups were found. PMID 16839405 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus GG Other / unclassified — Oral
Subject Lactobacillus rhamnosus Other / unclassified — Oral

Indications